Skip to content

Biohaven BHVN Change in AP

Change in AP at other companies

Eli Lilly logo
Eli LillyLLY
$2.55B+290%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
-$1.8M+52.4%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
$2.31M+1,146%
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
-$4.23M-199%
uniQure logo
uniQureQURE
-$557K+73.4%
Roivant Sciences logo
Roivant SciencesROIV
$16.16M+9,891%

Other financials

Income statement

See full
Operating income-$130.4M+41.1%
Net income-$130.5M+41.1%
EPS (diluted)-$0.88+59.4%

Balance sheet

See full
Cash & equivalents$277.1M+170%
Total debt$286.2M+706%
Total equity$129.5M-50.1%
Total assets$466.4M+1.6%

Cash flow

See full
Operating cash flow-$149.9M+9.2%
CapEx--100%
Free cash flow-$149.9M+9.5%

Valuation

See full
Market cap$2.25B-48.1%

Returns & leverage

See full
Return on equity-333%+17.9pp
Debt / equity2.2×+2.1×
Current ratio7.4×+5.1×

Where this comes from

Reported directly by Biohaven in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.

The official record: Biohaven’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biohaven's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biohaven's change in AP?
Biohaven (BHVN) reported change in AP of -$1.22M in Q1 2026.
How has Biohaven's change in AP changed year-over-year?
Biohaven's change in AP decreased by 1441.8% year-over-year, from $91K to -$1.22M.
What is the long-term trend for Biohaven's change in AP?
Over 2 years (2021 to 2025), Biohaven's change in AP has grown at a 149.6% compound annual growth rate (CAGR), from $1.03M to -$6.39M.
What does change in AP mean?
Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.